Business

Wendy’s rejects a $1.4 billion bid and adopts a poison pill

The board unanimously turned down the Trian-led offer of $7.35 a share, which sat below where the stock was already trading.

Exterior of the Wendy’s flagship restaurant in Dublin, Ohio under a blue sky
Photo: Nheyob via Wikimedia Commons (CC BY-SA 4.0)

Wendy’s independent directors unanimously rejected an unsolicited $7.35 a share takeover proposal from a group led by Trian Partners on Thursday.

Zoom in: The investor group of Trian Fund Management, Flynn Group, BlueFive Capital and Sixth Street Partners offered $7.35 in cash for every Wendy’s share it does not already own.

  • Wendy’s stock traded at $7.75 before Thursday’s open, above the offer price, and has slumped nearly 14% over the past 12 months.

Between the lines: The board adopted a limited-duration shareholder rights plan on November 4 that expires on November 3, 2027 and triggers if any person or group crosses 15% ownership without board approval.

  • Directors noted that the investor group had turned down an offer to sign a customary standstill agreement.

By the numbers: US same-restaurant sales fell 5.7% in the third quarter and revenue slipped to $547 million from $549.5 million a year earlier.

What they're saying: "The Independent Committee thoroughly evaluated this Proposal and unanimously concluded that it substantially undervalues Wendy’s standalone prospects and long-term earnings potential," board chairman Art Winkleblack said.

Why it matters: Wendy’s is pinning its defense on a turnaround plan called Dave’s Way, so the chain has to deliver traffic growth while an activist investor and a 15% trigger hang over the stock.

Go deeper: The Wendy’s Company (SEC filing)

Also: CBS News

  • wendys
  • mergers and acquisitions
  • activist investors
  • fast food

Newsletter

Get the daily brief

The day's stories and one idea to get 1% better, in a free five-minute email every morning.

Get Started
All news